Anson Funds Management LP Caladrius Biosciences, Inc. Transaction History

Anson Funds Management LP

  • $607 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$0.63 - $1.03 $106,742 - $174,514
-169,432 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.83 - $1.22 $140,628 - $206,707
169,432 New
169,432 $143,000
Q1 2021

May 14, 2021
SELL
$1.44 - $2.89 $347,148 - $696,706
-241,075 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$1.39 - $1.87 $335,094 - $450,810
241,075 New
241,075 $345,000

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Anson Funds Management LP Portfolio

Follow Anson Funds Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Anson Funds Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email